Basic Science Research
The Rocky Mountain MS Center at University of Colorado (RMMSC at CU) combines one of the most robust MS research programs in the nation with an innovative care model serving more than 4,200 patients a year. The RMMSC at CU conducts basic science and translational research and has more than 30 clinical trials underway at any given time. Our physicians and scientists play a critical role in the development of current and everging MS therapies, as well as studies to determin the biological basis of the disease. Currently, this research is supported by the National Institutes of Health, the National Multiple Sclerosis Society and the Rocky Mountain MS Center. Exciting studies underway include:
|
|